Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fluorine-containing drugs approved by the FDA in 2019
Haibo Mei, Attila Márió Remete, Yupiao Zou, et al.
Chinese Chemical Letters (2020) Vol. 31, Iss. 9, pp. 2401-2413
Closed Access | Times Cited: 195

Showing 1-25 of 195 citing articles:

U.S. FDA Approved Drugs from 2015–June 2020: A Perspective
Priyadeep Bhutani, Gaurav Joshi, Nivethitha Raja, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 5, pp. 2339-2381
Closed Access | Times Cited: 506
Chemical Aspects of Human and Environmental Overload with Fluorine
Jianlin Han, Lóránd Kiss, Haibo Mei, et al.
Chemical Reviews (2021) Vol. 121, Iss. 8, pp. 4678-4742
Open Access | Times Cited: 325
Biological Utility of Fluorinated Compounds: from Materials Design to Molecular Imaging, Therapeutics and Environmental Remediation
Cheng Zhang, Kai Yan, Changkui Fu, et al.
Chemical Reviews (2021) Vol. 122, Iss. 1, pp. 167-208
Closed Access | Times Cited: 289
Next generation organofluorine containing blockbuster drugs
Jianlin Han, Attila Márió Remete, Luca S. Dobson, et al.
Journal of Fluorine Chemistry (2020) Vol. 239, pp. 109639-109639
Open Access | Times Cited: 239
Fluorinated Pyrazoles: From Synthesis to Applications
Pavel K. Mykhailiuk
Chemical Reviews (2020) Vol. 121, Iss. 3, pp. 1670-1715
Closed Access | Times Cited: 228
Fluorine-containing pharmaceuticals approved by the FDA in 2020: Synthesis and biological activity
Yingjie Yu, Aiyao Liu, Gagan Dhawan, et al.
Chinese Chemical Letters (2021) Vol. 32, Iss. 11, pp. 3342-3354
Closed Access | Times Cited: 129
Fluorine-containing drugs approved by the FDA in 2021
Jingrui He, Ziyi Li, Gagan Dhawan, et al.
Chinese Chemical Letters (2022) Vol. 34, Iss. 1, pp. 107578-107578
Closed Access | Times Cited: 112
FDA-Approved Trifluoromethyl Group-Containing Drugs: A Review of 20 Years
Aathira Sujathan Nair, Ashutosh Kumar Singh, Astik Kumar, et al.
Processes (2022) Vol. 10, Iss. 10, pp. 2054-2054
Open Access | Times Cited: 94
FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022
Carla Rizzo, Sara Amata, Ivana Pibiri, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7728-7728
Open Access | Times Cited: 50
Highlights on U.S. FDA-approved fluorinated drugs over the past five years (2018–2022)
Saghir Ali, Jia Zhou
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115476-115476
Open Access | Times Cited: 49
Chemistry and Pharmacology of Fluorinated Drugs Approved by the FDA (2016–2022)
Ghulam Shabir, Aamer Saeed, Wajeeha Zahid, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1162-1162
Open Access | Times Cited: 45
Fluorine-a small magic bullet atom in the drug development: perspective to FDA approved and COVID-19 recommended drugs
Girish Chandra, Durg Vijay Singh, Gopal Kumar Mahato, et al.
Chemical Papers (2023) Vol. 77, Iss. 8, pp. 4085-4106
Open Access | Times Cited: 44
A review: FDA-approved fluorine-containing small molecules from 2015 to 2022
Negar Sheikhi, Maryam Bahraminejad, Mina Saeedi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115758-115758
Closed Access | Times Cited: 43
Latest developments in coumarin-based anticancer agents: mechanism of action and structure–activity relationship studies
Manankar Koley, Jianlin Han, Vadim A. Soloshonok, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 10-54
Open Access | Times Cited: 40
FDA approved fluorine-containing drugs in 2023
Qian Wang, Yeping Bian, Gagan Dhawan, et al.
Chinese Chemical Letters (2024) Vol. 35, Iss. 11, pp. 109780-109780
Closed Access | Times Cited: 16
Modern approaches towards the synthesis of geminal difluoroalkyl groups
Dayanne R. Carvalho, Alec H. Christian
Organic & Biomolecular Chemistry (2021) Vol. 19, Iss. 5, pp. 947-964
Closed Access | Times Cited: 64
Reductive quenching-initiated catalyst-controlled divergent alkylation of α-CF3-olefins
Yunxiao Zhang, Yizhi Zhang, You-Yuan Guo, et al.
Chem Catalysis (2022) Vol. 2, Iss. 6, pp. 1380-1393
Open Access | Times Cited: 49
The Latest FDA-Approved Pharmaceuticals Containing Fragments of Tailor-Made Amino Acids and Fluorine
Qian Wang, Jianlin Han, Alexander E. Sorochinsky, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 999-999
Open Access | Times Cited: 42
New Approved Drugs Appearing in the Pharmaceutical Market in 2022 Featuring Fragments of Tailor-Made Amino Acids and Fluorine
Nana Wang, Haibo Mei, Gagan Dhawan, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3651-3651
Open Access | Times Cited: 29
Cyclic tailor-made amino acids in the design of modern pharmaceuticals
Jiang Liu, Jianlin Han, Kunisuke Izawa, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112736-112736
Closed Access | Times Cited: 57
Application of Langlois’ reagent (NaSO2CF3) in C–H functionalisation
Jiabin Shen, Jun Xu, Lei He, et al.
Chinese Chemical Letters (2021) Vol. 33, Iss. 3, pp. 1227-1235
Closed Access | Times Cited: 54
Recent Advances in Synthesis of Difluoromethylene Phosphonates for Biological Applications
Michael Shevchuk, Qian Wang, Romana Pajkert, et al.
Advanced Synthesis & Catalysis (2021) Vol. 363, Iss. 12, pp. 2912-2968
Closed Access | Times Cited: 53
Development of N-F fluorinating agents and their fluorinations: Historical perspective
Teruo Umemoto, Yuhao Yang, Gerald B. Hammond
Beilstein Journal of Organic Chemistry (2021) Vol. 17, pp. 1752-1813
Open Access | Times Cited: 50
Recent advances in radical-based C–F bond activation of polyfluoroarenes and gem-difluoroalkenes
Junlei Wang, Han Gao, Chengcheng Shi, et al.
Chemical Communications (2021) Vol. 57, Iss. 92, pp. 12203-12217
Closed Access | Times Cited: 49
Design, synthesis, and biological evaluation of nitroisoxazole-containing spiro[pyrrolidin-oxindole] derivatives as novel glutathione peroxidase 4/mouse double minute 2 dual inhibitors that inhibit breast adenocarcinoma cell proliferation
Shuai‐Jiang Liu, Qian Zhao, Cheng Peng, et al.
European Journal of Medicinal Chemistry (2021) Vol. 217, pp. 113359-113359
Closed Access | Times Cited: 47
Page 1 - Next Page

Scroll to top